Adam Johnson
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
- Oncology 20
- CAR-T cell therapy research 18
-
- Antifungal resistance and susceptibility 8
- Co-authors
- William Hope (16 shared papers)Laura McEntee (14 shared papers)Michael C. Jensen (13 shared papers)Cindy A. Chang (6 shared papers)Lisa S. Rolczynski (4 shared papers)Annette Künkele (4 shared papers)Sarah Whalley (8 shared papers)Virginia J. Hoglund (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (9 papers)Blood (6 papers)Journal of Antimicrobial Chemotherapy (4 papers)The Journal of Immunology (3 papers)Cancer Immunology Research (3 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Adam Johnson
46 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 98
- Molecular Medicine 122
- Infectious Diseases 325
- Oncology 417
- Pharmacology 197
- Epidemiology 367
Countries citing papers authored by Adam Johnson
This map shows the geographic impact of Adam Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Johnson more than expected).
Fields of papers citing papers by Adam Johnson
This network shows the impact of papers produced by Adam Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Johnson. The network helps show where Adam Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Adam Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 130 | |
| 2 | 2015 | 88 | |
| 3 | 2016 | 75 | |
| 4 | 2013 | 58 | |
| 5 | 1988 | 54 | |
| 6 | 2017 | 54 | |
| 7 | 2019 | 50 | |
| 8 | 2018 | 50 | |
| 9 | 2019 | 49 | |
| 10 | 2017 | 49 | |
| 11 | 2019 | 46 | |
| 12 | 2017 | 43 | |
| 13 | 2019 | 39 | |
| 14 | 2018 | 36 | |
| 15 | 2016 | 36 | |
| 16 | 1996 | 27 | |
| 17 | 2017 | 27 | |
| 18 | 2015 | 24 | |
| 19 | 2018 | 23 | |
| 20 | 2022 | 20 |
About Adam Johnson
Adam Johnson is a scholar working on Oncology, Infectious Diseases, Pharmacology, Epidemiology and Immunology, having authored 57 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (18 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Antifungal resistance and susceptibility (8 papers), Immune Cell Function and Interaction (5 papers), Fungal Infections and Studies (5 papers), T-cell and B-cell Immunology (4 papers), Neonatal and Maternal Infections (4 papers) and Antibiotic Resistance in Bacteria (4 papers). The work is most often cited by research in Molecular Medicine (122 citations), Infectious Diseases (325 citations), Oncology (417 citations), Pharmacology (197 citations) and Epidemiology (367 citations). Adam Johnson has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include William Hope, Laura McEntee, Michael C. Jensen, Cindy A. Chang, Lisa S. Rolczynski, Annette Künkele, Sarah Whalley, Virginia J. Hoglund, Joanne Goodwin and Joanne Livermore. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Blood, Journal of Antimicrobial Chemotherapy, The Journal of Immunology and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.